Hospital study tracks eye drop risks in 1,000 patients

This study will monitor 1,000 hospitalized patients who receive tropicamide/phenylephrine eye drops, commonly used to dilate pupils before eye surgery. Researchers will measure vital signs and ask about side effects at several time points after the drops are given. The goal is to identify which patients are more likely to have adverse reactions, such as high blood pressure or eye discomfort.